M
Monte Rosa Therapeutics Inc
NASDAQ:GLUE
Monte Rosa Therapeutics Inc
NASDAQ:GLUE
Price:
17.75
USD
-4.05%
Market Closed
Market Cap:
$1.3B
Cash Flow Statement
Cash Flow Statement
Monte Rosa Therapeutics Inc
Monte Rosa Therapeutics Inc
Currency: USD
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||
| Net Income |
(36)
|
(44)
|
(57)
|
(70)
|
(74)
|
(86)
|
(94)
|
(101)
|
(109)
|
(117)
|
(125)
|
(133)
|
(135)
|
(135)
|
(130)
|
(119)
|
(73)
|
6
|
24
|
21
|
|
| Depreciation & Amortization |
1
|
1
|
1
|
2
|
2
|
3
|
3
|
3
|
4
|
4
|
5
|
5
|
6
|
7
|
8
|
8
|
8
|
8
|
8
|
8
|
|
| Stock-Based Compensation |
0
|
1
|
2
|
4
|
5
|
7
|
9
|
10
|
12
|
13
|
15
|
16
|
17
|
18
|
18
|
18
|
18
|
19
|
19
|
19
|
|
| Other Non-Cash Items |
8
|
9
|
10
|
12
|
6
|
7
|
10
|
13
|
14
|
15
|
14
|
13
|
13
|
15
|
16
|
15
|
15
|
15
|
15
|
16
|
|
| Change in Working Capital |
4
|
0
|
3
|
3
|
6
|
3
|
1
|
2
|
(2)
|
9
|
14
|
17
|
72
|
55
|
46
|
39
|
91
|
6
|
(20)
|
104
|
|
| Cash from Operating Activities |
(23)
N/A
|
(33)
-45%
|
(43)
-28%
|
(54)
-25%
|
(59)
-10%
|
(73)
-23%
|
(80)
-10%
|
(83)
-4%
|
(92)
-12%
|
(88)
+4%
|
(93)
-5%
|
(97)
-4%
|
(44)
+55%
|
(59)
-34%
|
(61)
-4%
|
(57)
+6%
|
42
N/A
|
35
-17%
|
28
-20%
|
149
+438%
|
|
| Investing Cash Flow | |||||||||||||||||||||
| Capital Expenditures |
(3)
|
(6)
|
(7)
|
(8)
|
(10)
|
(9)
|
(9)
|
(9)
|
(13)
|
(20)
|
(24)
|
(25)
|
(19)
|
(11)
|
(7)
|
(5)
|
(4)
|
(4)
|
(4)
|
(4)
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
(179)
|
(190)
|
(160)
|
(206)
|
2
|
39
|
45
|
108
|
90
|
5
|
6
|
(40)
|
(150)
|
(64)
|
(64)
|
|
| Cash from Investing Activities |
(3)
N/A
|
(6)
-65%
|
(7)
-26%
|
(8)
-11%
|
(10)
-24%
|
(188)
-1 848%
|
(200)
-6%
|
(168)
+16%
|
(219)
-30%
|
(18)
+92%
|
14
N/A
|
21
+42%
|
89
+332%
|
78
-12%
|
(1)
N/A
|
1
N/A
|
(44)
N/A
|
(155)
-248%
|
(68)
+56%
|
(68)
+1%
|
|
| Financing Cash Flow | |||||||||||||||||||||
| Net Issuance of Common Stock |
61
|
204
|
398
|
381
|
381
|
238
|
31
|
0
|
21
|
21
|
22
|
23
|
27
|
28
|
125
|
123
|
99
|
99
|
1
|
1
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
(0)
|
(1)
|
(2)
|
(3)
|
(3)
|
(3)
|
(2)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
60
N/A
|
203
+238%
|
396
+95%
|
378
-5%
|
378
0%
|
235
-38%
|
30
-87%
|
(0)
N/A
|
20
N/A
|
20
-1%
|
21
+5%
|
23
+6%
|
27
+21%
|
28
+1%
|
125
+349%
|
123
-1%
|
99
-20%
|
99
0%
|
1
-99%
|
1
+33%
|
|
| Change in Cash | |||||||||||||||||||||
| Net Change in Cash |
34
N/A
|
164
+387%
|
346
+111%
|
316
-9%
|
309
-2%
|
(26)
N/A
|
(250)
-863%
|
(251)
-1%
|
(291)
-16%
|
(87)
+70%
|
(57)
+34%
|
(54)
+6%
|
72
N/A
|
47
-34%
|
62
+31%
|
67
+8%
|
96
+44%
|
(21)
N/A
|
(39)
-85%
|
83
N/A
|
|
| Free Cash Flow | |||||||||||||||||||||
| Free Cash Flow |
(26)
N/A
|
(39)
-48%
|
(50)
-28%
|
(62)
-23%
|
(69)
-12%
|
(82)
-19%
|
(89)
-8%
|
(91)
-3%
|
(105)
-15%
|
(109)
-3%
|
(118)
-8%
|
(122)
-4%
|
(63)
+48%
|
(70)
-11%
|
(68)
+3%
|
(63)
+7%
|
38
N/A
|
30
-20%
|
24
-22%
|
145
+508%
|
|
Switch to:
Switch to:
See Also
Discover More
